Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antifungal, antitubercular and miscellaneous anti-infective agents.

Rodvold KA, Yoo L, George JM.

Clin Pharmacokinet. 2011 Nov 1;50(11):689-704. doi: 10.2165/11592900-000000000-00000. Review.

PMID:
21973267
2.

Effect of sex and AIDS status on the plasma and intrapulmonary pharmacokinetics of rifampicin.

Conte JE, Golden JA, Kipps JE, Lin ET, Zurlinden E.

Clin Pharmacokinet. 2004;43(6):395-404.

PMID:
15086276
3.

Effects of gender, AIDS, and acetylator status on intrapulmonary concentrations of isoniazid.

Conte JE Jr, Golden JA, McQuitty M, Kipps J, Duncan S, McKenna E, Zurlinden E.

Antimicrob Agents Chemother. 2002 Aug;46(8):2358-64. Erratum in: Antimicrob Agents Chemother. 2002 Sep;46(9):3112..

4.

Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents.

Rodvold KA, George JM, Yoo L.

Clin Pharmacokinet. 2011 Oct;50(10):637-64. doi: 10.2165/11594090-000000000-00000. Review.

PMID:
21895037
5.

Zanamivir pharmacokinetics and pulmonary penetration into epithelial lining fluid following intravenous or oral inhaled administration to healthy adult subjects.

Shelton MJ, Lovern M, Ng-Cashin J, Jones L, Gould E, Gauvin J, Rodvold KA.

Antimicrob Agents Chemother. 2011 Nov;55(11):5178-84. doi: 10.1128/AAC.00703-11. Epub 2011 Sep 6.

6.

Intrapulmonary pharmacokinetics of linezolid.

Conte JE Jr, Golden JA, Kipps J, Zurlinden E.

Antimicrob Agents Chemother. 2002 May;46(5):1475-80.

7.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
8.

Concentration of enrofloxacin and its active metabolite in alveolar macrophages and pulmonary epithelial lining fluid of dogs.

Hawkins EC, Boothe DM, Guinn A, Aucoin DP, Ngyuen J.

J Vet Pharmacol Ther. 1998 Feb;21(1):18-23.

PMID:
9507453
9.

Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state.

Conte JE Jr, Golden JA, Kipps J, McIver M, Zurlinden E.

Antimicrob Agents Chemother. 2004 Oct;48(10):3823-7.

10.

Intrapulmonary pharmacokinetics and pharmacodynamics of micafungin in adult lung transplant patients.

Walsh TJ, Goutelle S, Jelliffe RW, Golden JA, Little EA, DeVoe C, Mickiene D, Hayes M, Conte JE Jr.

Antimicrob Agents Chemother. 2010 Aug;54(8):3451-9. doi: 10.1128/AAC.01647-09. Epub 2010 May 3.

12.

Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects.

Wenzler E, Gotfried MH, Loutit JS, Durso S, Griffith DC, Dudley MN, Rodvold KA.

Antimicrob Agents Chemother. 2015 Dec;59(12):7232-9. doi: 10.1128/AAC.01713-15. Epub 2015 Sep 8.

13.

Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.

Rodvold KA, Danziger LH, Gotfried MH.

Antimicrob Agents Chemother. 2003 Aug;47(8):2450-7.

14.

Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults.

Crandon JL, Banevicius MA, Fang AF, Crownover PH, Knauft RF, Pope JS, Russomanno JH, Shore E, Nicolau DP, Kuti JL.

Antimicrob Agents Chemother. 2009 Dec;53(12):5102-7. doi: 10.1128/AAC.01042-09. Epub 2009 Sep 21.

15.

Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers.

Housman ST, Pope JS, Russomanno J, Salerno E, Shore E, Kuti JL, Nicolau DP.

Antimicrob Agents Chemother. 2012 May;56(5):2627-34. doi: 10.1128/AAC.05354-11. Epub 2012 Feb 13.

16.

Single-dose intrapulmonary pharmacokinetics of rifapentine in normal subjects.

Conte JE Jr, Golden JA, McQuitty M, Kipps J, Lin ET, Zurlinden E.

Antimicrob Agents Chemother. 2000 Apr;44(4):985-90.

17.

Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.

Conte JE Jr, Golden JA, McIver M, Zurlinden E.

Int J Antimicrob Agents. 2006 Aug;28(2):114-21. Epub 2006 Jul 11.

PMID:
16837169
18.

Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations.

Groll AH, Lyman CA, Petraitis V, Petraitiene R, Armstrong D, Mickiene D, Alfaro RM, Schaufele RL, Sein T, Bacher J, Walsh TJ.

Antimicrob Agents Chemother. 2006 Oct;50(10):3418-23.

19.

Intrapulmonary pharmacokinetics of ofloxacin in drug-resistant tuberculosis.

Chierakul N, Klomsawat D, Chulavatnatol S, Chindavijak B.

Int J Tuberc Lung Dis. 2001 Mar;5(3):278-82.

PMID:
11326828
20.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278

Supplemental Content

Support Center